foxo4 dri peptide FOXO4-DRI FOXO4-DRI regulates endothelial cell senescence

Pickart holdS the patent on GHK and 2nd generation copper peptides

Some small-scale studies have suggested potential benefits in hair regrowth, but no adequately powered, placebo-controlled head-to-head trial has demonstrated that copper peptides perform comparably to 5% minoxidil

Subcutaneous injection technique for GHK-Cu Proper administration ensures results and safety

The "right" dose sits in a narrow window that depends on: Delivery method - injectable GHK-Cu vs topical GHK-Cu vs oral/sublingual GHK-Cu Goal - skin rejuvenation , hair and scalp support, wound healing , general anti-ageing Individual factors - age , skin type , baseline GHK levels , other peptides being stacked Natural plasma GHK falls from roughly 200 ng/ml at age 20 to around 80 ng/ml by age 60

As a result, the disparity between safety profiles for GHK-Cu injection vs topical delivery methods is considerable

We reasoned such a brake could potentially be a transcriptional regulator and focused on transcription factors that have previously been linked to apoptosis, including STAT1, 2 and 4, RELB, NFB, TP53 and FOXO4 (Fig